ESR 1150 CL

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ESR 1150 CL, covering 2014-07-08 to 2014-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ESR 1150 CL in Healthy Subjects [Phase 1]